| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |